{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-090107","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2025-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.465265+00:00","generated_at":"2026-05-17T06:00:32.091967+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"CERO Therapeutics updates investor presentation with no material new disclosures","bullets":["Company furnished updated corporate presentation dated September 2025 as Exhibit 99.1, intended for investor meetings.","No financial results, clinical updates, or guidance were included in the filing or the attached exhibit text.","Presentation available on company website but substantive content not extracted from the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-090107","json":"https://secwatch.observer/filing/0001213900-25-090107.json","markdown":"https://secwatch.observer/filing/0001213900-25-090107.md","text":"https://secwatch.observer/filing/0001213900-25-090107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390025090107/0001213900-25-090107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390025090107/ea0258166-8k_cero.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:00:32.091967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}